Cefdinir

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 68071-5106
  • Package NDC 68071-5106-6
  • Application number ANDA065473
  • SPL ID 1b46ce4d-fa1c-4ce1-e063-6394a90a15f3
  • SPL set ID 96cad498-70d3-3089-e053-2995a90a9d19
  • UNII CI0FAO63WC
  • RxCUI 476576

What the source publishes

Labeler
NuCare Pharmaceuticals,Inc.
Active ingredients
Cefdinir
Form
POWDER, FOR SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:68071-5106_1b46ce4d-fa1c-4ce1-e063-6394a90a15f3
{
  "name": "Cefdinir",
  "splId": "1b46ce4d-fa1c-4ce1-e063-6394a90a15f3",
  "labels": [
    {
      "setId": "96cad498-70d3-3089-e053-2995a90a9d19",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96cad498-70d3-3089-e053-2995a90a9d19",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=96cad498-70d3-3089-e053-2995a90a9d19"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "NuCare Pharmaceuticals,Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "60 mL in 1 BOTTLE (68071-5106-6)",
      "package_ndc": "68071-5106-6",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20191107"
    }
  ],
  "productId": "68071-5106_1b46ce4d-fa1c-4ce1-e063-6394a90a15f3",
  "useDomain": "unknown",
  "dosageForm": "POWDER, FOR SUSPENSION",
  "productNdc": "68071-5106",
  "deaSchedule": null,
  "genericName": "Cefdinir",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CEFDINIR",
      "strength": "250 mg/5mL"
    }
  ],
  "applicationNumber": "ANDA065473",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20071214",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175488",
      "M0003827"
    ],
    "upc": [
      "0368071510669"
    ],
    "unii": [
      "CI0FAO63WC"
    ],
    "rxcui": [
      "476576"
    ],
    "spl_set_id": [
      "96cad498-70d3-3089-e053-2995a90a9d19"
    ],
    "pharm_class_cs": [
      "Cephalosporins [CS]"
    ],
    "pharm_class_epc": [
      "Cephalosporin Antibacterial [EPC]"
    ],
    "manufacturer_name": [
      "NuCare Pharmaceuticals,Inc."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:68071-5106_1b46ce4d-fa1c-4ce1-e063-6394a90a15f3"